Nov, 7 2021 Britain has become the first country in the world to approve Lagevrio (molnupiravir). The drug is touted as a potential game changer for the management of COVID-19 patients. The Medicines and Healthcare products Regulatory Agency (MHRA), the…
Oct, 24 2020 Gilead Lifesciences Inc.'s Veklury (Remdesivir) has become the first treatment for COVID-19 to receive the U.S. Food and Drug Administration approval. The drug is approved for use in adult and pediatric patients 12 years of age and older…
July 6, 2020 Gilead Sciences has announced that the European Commission has granted conditional marketing authorization for Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. The conditional marketing authorization was granted in the interest of public…
Jun 17, 2020 Dexamethasone, a low cost corticosteroid available in tablet as well as injectable form has become the first drug to show survival improvement in critically ill cornoavirus patients. As per the study conducted in UK, Researchers found that…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
